本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

NLS Pharmaceutics Ltd.

1.50
+0.03002.04%
盤後1.45-0.0499-3.33%19:18 EDT
成交量:2.55萬
成交額:3.71萬
市值:175.79萬
市盈率:-0.23
高:1.50
開:1.46
低:1.43
收:1.47
資料載入中...
2025/04/15

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2025/03/31

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2025/03/10

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2025/02/25

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2025/02/10

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2025/01/31

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2025/01/28

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2025/01/16

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2025/01/08

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2024/12/30

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2024/12/19

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2024/12/11

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2024/11/25

SEC問詢函

Form CORRESP - Correspondence
2024/11/21

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/18

SEC問詢函

Form CORRESP - Correspondence
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/06

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2024/11/04

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/04

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]